Sabra Healthcare REIT Inc (NASDAQ:SBRA) saw a downside of -2.20% to close Tuesday at $13.75 after subtracting -$0.31 on the day. The 5-day average trading volume is 3,291,340 shares of the company’s common stock. It has gained $14.32 in the past week and touched a new high 2 times within the past 5 days. An average of 3,087,760 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,469,646.
SBRA’s 1-month performance is 14.11% or $1.70 on its low of $12.10 reached on 08/29/23. The company’s shares have touched a 52-week low of $10.08 and high of $14.32, with the stock’s rally to the 52-week high happening on 09/22/23. YTD, SBRA has achieved 10.62% or $1.32 and has reached a new high 13 times. However, the current price is down -3.98% from the 52-week high price.
Valuation Metrics
SBRA stock has a beta of 1.25. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 5.05 while the price-to-book (PB) in the most recent quarter is 1.08, with the price to cash flow ratio at 10.09.
As well, the company’s long term debt to equity for the quarter ending June 29 was 0.83, while the total debt to equity was 0.84.. In terms of profitability, the gross margin trailing 12 months is 40.25%. The firm’s gross profit as reported stood at $140.66 million against revenue of $624.81 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 20.67% to $21.19 million, while revenue of -$9.49 million was 144.79% off the previous quarter. Analysts expected SBRA to announce $0.1 per share in earnings in its latest quarter, but it posted $0.09, representing a -10.00% surprise. EBITDA for the quarter stood at more than $102.47 million. Shareholders hold equity totaling $231.22 million.
Let’s look briefly at Sabra Healthcare REIT Inc (SBRA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 26 September was 64.46% to suggest the stock is trending Neutral, with historical volatility in this time period at 24.67%.
The stock’s 5-day moving average is $13.91, reflecting a +2.92% or $0.39 change from its current price. SBRA is currently trading +13.17% above its 20-day SMA, +21.25% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +9.21% and SMA200 by+7.93%.
Stochastic %K and %D was 78.16% and 82.46% and the average true range (ATR) pointed at 0.33. The RSI (14) points at 64.72%, while the 14-day stochastic is at 67.98% with the period’s ATR at 0.32. The stock’s 9-day MACD Oscillator is pointing at 0.25 and 0.46 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Sabra Healthcare REIT Inc (NASDAQ: SBRA), Jefferies upgraded it to a Buy rating. They previously had a Hold rating on the stock. Analysts offering their rating for SBRA stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate SBRA as a “sell,”, while 9 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 5 have offered a “buy” rating.
What is SBRA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $12.50 and a high of $15.00, with their median price target at $13.50. Looking at these predictions, the average price target given by analysts is for Sabra Healthcare REIT Inc (SBRA) stock is $13.63.
